Literature DB >> 8826934

Relapsing oral and colonic ulcers with monoclonal T-cell infiltration. A low grade mucosal T-lymphoproliferative disease of the digestive tract.

N Egawa1, M Fukayama, K Kawaguchi, T Hishima, Y Hayashi, N Funata, T Ibuka, M Koike, H Miyashita, T Tajima.   

Abstract

BACKGROUND: Some cutaneous T-cell lymphoproliferative diseases (LPD), such as lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta, are characterized by an indolent or waning and waxing clinical course. However, such T-cell LPD are rarely documented in other organs.
METHODS: A patient with T-cell LPD of the digestive tract characterized by repetitive episodes of self-healing ulcers in the oral and intestinal mucosa over the course of 17 years is reported. Biopsy specimens from oral and intestinal mucosa were studied by conventional pathology, immunocytochemistry, and Southern blot analysis of T-cell receptor (TCR)-beta and -gamma gene rearrangement.
RESULTS: Immunocytochemically, the infiltrating lymphocytes were lamina propria T cells with a dominant phenotype CD3+, CD4+/-, CD8-, and HML-1-. DNA study revealed the same rearranged configuration of TCR-beta and -gamma genes in specimens from both oral and colonic lesions.
CONCLUSIONS: The present case may represent a novel T-cell lymphoproliferative disease (i.e., a digestive-tract mucosal counterpart of cutaneous dysplastic LPD).

Entities:  

Mesh:

Year:  1995        PMID: 8826934     DOI: 10.1002/1097-0142(19950401)75:7<1728::aid-cncr2820750727>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  T-cell and NK-cell neoplasms of the gastrointestinal tract - recurrent themes, but clinical and biological distinctions exist.

Authors:  Elaine S Jaffe
Journal:  Haematologica       Date:  2020-07       Impact factor: 9.941

Review 2.  Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Authors:  Karthik A Ganapathi; Stefania Pittaluga; Oreofe O Odejide; Arnold S Freedman; Elaine S Jaffe
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

3.  Indolent T-cell lymphoproliferative disease of the gastrointestinal tract after treatment with adalimumab in resistant Crohn's colitis.

Authors:  Natalia Edison; Hila Belhanes-Peled; Yuval Eitan; Yifat Guthmann; Yelena Yeremenko; Mark Raffeld; Irit Elmalah; Philippe Trougouboff
Journal:  Hum Pathol       Date:  2016-07-08       Impact factor: 3.466

4.  Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.

Authors:  Anamarija M Perry; Roger A Warnke; Qinglong Hu; Philippe Gaulard; Christiane Copie-Bergman; Serhan Alkan; Huan-You Wang; Jason X Cheng; Chris M Bacon; Jan Delabie; Erik Ranheim; Can Kucuk; Xiaozhou Hu; Dennis D Weisenburger; Elaine S Jaffe; Wing C Chan
Journal:  Blood       Date:  2013-09-05       Impact factor: 22.113

5.  Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract.

Authors:  Anamarija M Perry; Nathanael G Bailey; Michelle Bonnett; Elaine S Jaffe; Wing C Chan
Journal:  Int J Surg Pathol       Date:  2018-07-09       Impact factor: 1.271

6.  NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series.

Authors:  Adnan Mansoor; Stefania Pittaluga; Paul L Beck; Wyndham H Wilson; Judith A Ferry; Elaine S Jaffe
Journal:  Blood       Date:  2010-10-21       Impact factor: 22.113

7.  CD8-positive indolent T-Cell lymphoproliferative disorder of the gastrointestinal tract: A case report and review of literature.

Authors:  Chun-Yan Weng; Cheng Ye; Yi-Hong Fan; Bin Lv; Chun-Li Zhang; Meng Li
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

Review 8.  Cytotoxic T-cell lymphoma arising in Behçet disease.

Authors:  Yukitaka Katsura; Kazumi Suzukawa; Hiroshi Kojima; Chikashi Yoshida; Seiichi Shimizu; Harumi Mukai; Yuichi Hasegawa; Shigehiko Imagawa; Naoyoshi Mori; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

9.  Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features.

Authors:  Elizabeth Margolskee; Vaidehi Jobanputra; Suzanne K Lewis; Bachir Alobeid; Peter H R Green; Govind Bhagat
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

10.  An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.

Authors:  Xingen Wang; Chi-Sing Ng; Cuimin Chen; Guangyin Yu; Weihua Yin
Journal:  Diagn Pathol       Date:  2018-10-20       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.